Live Quote · NASDAQAMLXHealthcare· Biotechnology

Amylyx Pharmaceuticals, Inc.

$26.02▼ 0.69%($-0.18)
MKT CAP $3.35BNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
50
Valuation
20
Profitability
55
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMLX research report →

Analyst Price Target
$49.29+89.4% vs. today

Range $39 – $57

Analyst RatingBuy
10 Buy1 Hold0 Sell

Price Chart

+92.63% · this period
$39.66$25.52$11.38Nov 20May 26Nov 20
52-Week Range50% of range
Low
$10.83
Current
$26.02
High
$41.14